Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study.
Eiichi OgawaDae Won JunHidenori ToyodaYao-Chun HsuEileen L YoonSang Bong AhnMing-Lun YehSon DoHuy N TrinhHirokazu TakahashiMasaru EnomotoNorifumi KawadaSatoshi YasudaCheng-Hao TsengKeigo KawashimaHan-Ah LeeKaori InoueHiroaki HagaAi-Thien DoMayumi MaedaJoseph H HoangRamsey CheungYoshiyuki UenoYuichiro EguchiNorihiro FurusyoMing-Lung YuYasuhito TanakaMindie H NguyenPublished in: Alimentary pharmacology & therapeutics (2023)
At 24 months after the switch to TAF, VR rates and spine bone density improved significantly while renal function remained stable.